Cargando…

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

PURPOSE: To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi-institutional phase 2 randomized trial. METHODS AND MATERIALS: Men with favorable-risk prostate cancer were randomized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hathout, Lara, Mahmoud, Omar, Wang, Yaqun, Vergalasova, Irina, Barkati, Maroie, Després, Philippe, Martin, André-Guy, Foster, William, Lacroix, Frédéric, Delouya, Guila, Taussky, Daniel, Morton, Gerard, Vigneault, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Genitourinary Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817536/ https://www.ncbi.nlm.nih.gov/pubmed/31673656 http://dx.doi.org/10.1016/j.adro.2019.04.003

Ejemplares similares

Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results
por: Lauche, Olivier, et al.
Publicado: (2016)

Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions
por: Solanki, Abhishek A., et al.
Publicado: (2018)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Results of a Prospective Dose Escalation Study of Linear Accelerator–Based Virtual Brachytherapy (BOOSTER) for Prostate Cancer; Virtual HDR Brachytherapy for Prostate Cancer
por: Eade, Thomas, et al.
Publicado: (2019)

Building a High-Dose-Rate Prostate Brachytherapy Program With Real-Time Ultrasound-Based Planning: Initial Safety, Quality, and Outcome Results
por: Zhang, Hong, et al.
Publicado: (2020)

Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study
por: Dahn, Hannah M., et al.
Publicado: (2019)

The clinical impact of removing rectal gas on high‐dose‐rate brachytherapy dose distributions for gynecologic cancers
por: Vergalasova, Irina, et al.
Publicado: (2021)

Systemic Inflammatory Markers Are Predictive of the Response to Brachytherapy in the Prostate
por: Taussky, Daniel, et al.
Publicado: (2020)

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning
por: Lavoie-Gagnon, Heloise, et al.
Publicado: (2022)

Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy
por: Tiberi, David, et al.
Publicado: (2014)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication
por: Chira, Ciprian, et al.
Publicado: (2013)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)

The combined use of 2D scout and 3D axial CT images to accurately determine the catheter tips for high‐dose‐rate brachytherapy plans
por: Qing, Kun, et al.
Publicado: (2021)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer
por: Song, Jiheon, et al.
Publicado: (2020)

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
por: Viani, Gustavo A, et al.
Publicado: (2009)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022)

Prevention of high-dose-rate brachytherapy accidents
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)

High Dose Rate Brachytherapy - A Textbook
por: Ash, DV
Publicado: (1995)

Pulsed dose rate brachytherapy of lip cancer
por: Serkies, Krystyna, et al.
Publicado: (2013)

Pulsed dose rate brachytherapy – is it the right way?
por: Skowronek, Janusz
Publicado: (2010)

High dose rate brachytherapy for oral cancer
por: YamazakI, Hideya, et al.
Publicado: (2013)

High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
por: Cendales, Ricardo, et al.
Publicado: (2015)

Do androgen deprivation and the biologically equivalent dose matter in low‐dose‐rate brachytherapy for intermediate‐risk prostate cancer?
por: Tabata, Ryuji, et al.
Publicado: (2016)

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data
por: Weg, Emily S., et al.
Publicado: (2019)

The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
por: Burchardt, Wojciech M., et al.
Publicado: (2023)

Comparison of Two High Dose Rate Brachytherapy Regimes
por: Jaswal, Gaurav, et al.
Publicado: (2023)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma
por: Bergerot, Cristiane, et al.
Publicado: (2023)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer
por: Polo, Alfredo
Publicado: (2010)

High-resolution, ultrasound-guided, high-dose-rate, surface brachytherapy for basal cell carcinoma of the skin: A case report
por: Zhu, Simeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2j78psh6427qnn4q2qensjtdrh